Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 10 of 12« First...89101112

U.S. House speaker says Obamacare replacement will pass this year

The U.S. House of Representatives’ Republican leader said legislation to replace former President Barack Obama’s signature healthcare law would be completed during 2017, trying to dispel the idea that the party is retreating from its campaign promise to dismantle Obamacare quickly.

Read More »

FTC sues Shire ViroPharma for fighting generic entry of Vancocin

The U.S. Federal Trade Commission filed a complaint against Shire ViroPharma, accusing it of abusing government processes in order to fend off generic competition to its antibiotic Vancocin HCl.

Read More »

What Is a Reflective Essay Report

Wagner tried diligently to discover gainful employment due to his pal. Individualism in our documents enables you to give a winning little bit of composing every time you will find an endeavor to. Before getting started, there are a significant few points you must be aware of about composing an article. When you have narrowed […]

Read More »

Trump’s Intentions to Streamline Drug-Approval Process Fueling Biotech Optimism

With Trump sticking to his campaign promises and point of view, coupled with his latest indications on the direction the industry is heading with concerns about drug prices, FDA approvals and regulations may be infusing somewhat of positive optimism in to the biotech/pharma industry.

Read More »

Teva CEO Abruptly Steps Down

Erez Vigodman has stepped down from his position as chief executive officer of Teva Pharmaceutical, the world’s largest generic drug manufacturer by sales.

Read More »

GE Healthcare to Shutter Maryland Plant, Nearly 200 Employees Affected

GE Healthcare is planning to close a facility in Laurel, Maryland affecting approximately 200 positions. The facility is being shut down as part of an effort to streamline operations in order to stay competitive, the Baltimore Sun reported.

Read More »

Genentech’s $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire

One of the first things President Trump did upon winning the election was change his website, greatagain.gov. On that site, his plans were updated to reflect intended policies for various things, including healthcare and bipharma. Of the six points for healthcare, one was, “Reform the Food and Drug Administration, to put greater focus on the need of patients for new and innovative medical products.” As yet, President Trump has not selected anyone to head the U.S. Food and Drug Administration, although one being vetted is Jim O’Neill – a former Health and Human Services Official.

Read More »

Merck KGaA Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson’s Trials

Prexton Therapeutics announced that it had closed a $31 million Series B financing round that was co-led by Forbion Capital Partners and Seroba Life Sciences. Current investors Merck Ventures, Ysios Capital and Sunstone Capital participated.

Read More »

Carmat pulls request to resume trial implantations

Artificial heart maker Carmat said it had decided to withdraw its initial request to France’s national drugs agency (ANSM) to resume trial implantations.

Read More »

Cellectis gets U.S. go-ahead to test ‘off-the-shelf’ cell therapy

The French biotech firm Cellectis won U.S. regulatory approval to run an early clinical trial using its gene edited cell therapy product UCART123 for blood cancers.

Read More »

The Great DTC Shake-Up: Patient insights on direct-to-consumer advertising

“The DTC Attitudes, Behaviors, and Preferences Survey” shows that patients are becoming increasing disengaged with DTC advertising despite spend by pharma increasing.

Read More »

Renova Therapeutics enters into agreement to receive stresscopin investigational new drug file from Janssen

Renova Therapeutics Inc. announced that it has entered into an agreement with Janssen Pharmaceuticals Inc., whereby the investigational new drug (IND) file for stresscopin – a hormone involved in responses to physiological stress – will be transferred from Janssen, where it was previously under development.

Read More »

Express Scripts: 2016 Rx drug spending slowed

Express Scripts Holding Co. – the largest U.S. pharmacy benefit manager – said prescription drug spending for its members slowed to less than 4 percent in 2016.

Read More »

Biotech Execs are Hoping Trump Will Pick This Man to Head the FDA

Industry leaders have their preference for a new FDA commissioner – Dr. Scott Gottlieb, a former deputy commissioner at the FDA. Gottlieb has strong ties to the pharmaceutical industry and currently serves as an adviser to several companies, including GlaxoSmithKline.

Read More »

Another Letdown for Bristol-Myers Squibb as Partner Innate Pharma’s Leukemia Candidate Flunks Phase II Test

Innate Pharma SA announced top-line results from a randomized, double-blind, placebo-controlled Phase II trial testing the efficacy of lirilumab as a single agent maintenance treatment in elderly patients with acute myeloid leukemia (AML) in first complete remission (“EffiKIR” trial). The study did not meet its primary efficacy endpoint of leukemia-free survival (LFS).

Read More »

Lilly Seeking “Voluntary Exits” From Researchers

After terminating 485 positions linked to its failed Alzheimer’s therapy solanezumab, Lilly aims to terminate another 3 percent of R&D staff, Endpoints reported.

Read More »

WPP launches WPP Health & Wellness

WPP announced the formation of WPP Health & Wellness, a new sub-holding company that unites WPP’s broad capability under one banner to significantly advance its offer and partnership with clients across the spectrum of health and wellness.

Read More »

LabCorp Could Makes $8 Billion+ Proposal to CRO PPD

Laboratory Corporation of America (LabCorp) could make an $8 billion bid in an auction to acquire Wilmington, N.C.-based Pharmaceutical Product Development LLC, Reuters reported.

Read More »

Who’ll DO MY ESSAY For Affordable?Do You Wish To Purchase ESSAYS For Cost-effective?Obtain TERM Paperwork For Cost-effective Of High Quality

Who’ll DO MY ESSAY For Affordable?Do You Wish To Purchase ESSAYS For Cost-effective?Obtain TERM Paperwork For Cost-effective Of High Quality CheapCustomWritings.online can be a reputed provider of specialist essay composing professional services at most of the inexpensive charges at any time. If you’re learning this site, what this means is you’re in search of the […]

Read More »

Who’ll DO MY ESSAY For Affordable?Do You Wish To Purchase ESSAYS For Cost-effective?Obtain TERM Paperwork For Cost-effective Of High Quality

Who’ll DO MY ESSAY For Affordable?Do You Wish To Purchase ESSAYS For Cost-effective?Obtain TERM Paperwork For Cost-effective Of High Quality CheapCustomWritings.online can be a reputed provider of specialist essay composing professional services at most of the inexpensive charges at any time. If you’re learning this site, what this means is you’re in search of the […]

Read More »

Page 10 of 12« First...89101112

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

February 2018 Focus: Top 10 Pipelines, Focused Value in Pharma, Agenda 2018 and MAHF!

Subscribe

Ad Right Bottom

Main Navigation